Melatonin inhibits endothelial nitric oxide production in vitro

Journal of Pineal Research

Volumn 41, Issue 3, 2006, Pages 267-274

  Tamura, Eduardo K ^a   Silva, Claudia L M ^a   Markus, Regina P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bradykinin; Calcium; Confocal microscopy; Endothelium; Melatonin; Nitric oxide

Indexed keywords

5 METHOXY CARBONYLAMINO N ACETYL TRYPTAMINE; BRADYKININ; CALCIUM ION; CALMIDAZOLIUM; CALMODULIN; CYCLIC GMP; MELATONIN; MELATONIN RECEPTOR; N ACETYLSEROTONIN; NITRIC OXIDE; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; IN VITRO STUDY; NONHUMAN; RAT;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; MALE; MELATONIN; NITRIC OXIDE; RATS; RATS, WISTAR;

EID: 33748363497     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2006.00366.x     Document Type: Article

References (59)

1. FINOCCHIARO LM, ARZT ES, FERNANDEZ-CASTELO S et al. Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway. J Interferon Res 1988; 8:705-716.
2. CARRILLO-VICO A, CALVO JR, ABREU P et al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 2004; 18:537-539.
3. MARTINS E, JR, FERREIRA AC, SKORUPA AL et al. Tryptophan consumption and indoleamines production by peritoneal cavity macrophages. J Leukoc Biol 2004; 75:1116-1121.
4. RÉGRIGNY O, DELAGRANGE P, SCALBERT E et al. Effects of melatonin on rat pial arteriolar diameter in vivo. Br J Pharmacol 1999; 127:1666-1670.
5. TING N, THAMBYRAJA A, SUGDEN D et al. Pharmacological studies on the inhibitory action of melatonin and putative melatonin analogues on porcine vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 2000; 361:327-333.
6. YANG Q, SCALBERT E, DELAGRANGE P et al. Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries. Am J Physiol 2001; 280:H76-H82.
7. VANDEPUTTE C, GIUMMELLY P, ATKINSON J et al. Melatonin potentiates NE-induced vasoconstriction without augmenting cytosolic calcium concentration. Br J Pharmacol 2001; 280:11420-11425.
8. LEW MJ, FLANDERS S. Mechanisms of melatonin-induced vasoconstriction in the rat tail artery: a paradigm of weak vasoconstriction. Br J Pharmacol 1999; 126:1408-1418.
9. + channels and endothelial factors. Br J Pharmacol 1998; 123:1533-1543.
10. LOTUFO CMC, LOPES C, DUBOCOVICH ML et al. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur J Pharmacol 2001; 430:351-357.
11. 2 melatonin receptors in mammals. Endocrine 2005; 27:101-110.
12. 3H-melatonin to calmodulin. Life Sci 1993; 53:201-207.
13. POZO D, REITER RJ, CALVO JR et al. Inhibition of cerebelar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997; 65:430-442.
14. LEON J, MACIAS M, ESCAMES G et al. Structure-related inhibition of calmodulin-dependent neuronal nitric oxide synthase activity by melatonin and synthetic kynurenines. Mol Pharmacol 2000; 58:967-975.
15. STORR M, KOPPITZ P, SIBAEV A et al. Melatonin reduces non-adrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro. J Pineal Res 2002; 33:101-108.
16. SAENZ DA, TURJANSKI AG, SACCA GB et al. Physiological concentrations of melatonin inhibit the nitridergic pathway in Syrian hamster retina. J Pineal Res 2002; 33:31-36.
17. CAPSONI S, VISWANATHAN M, OLIVEIRA AM et al. Characterization of melatonin receptors and signal transduction system in rat arteries forming the Circle of Willis. Endocrinology 1994; 153:373-378.
18. SELTZER A, VISWANATHAN M, SAAVEDRA JM. Melatoninbinding sites in brain and caudal arteries of the female rat during the estrous cycle and after estrogen administration. Endocrinology 1992; 130:1896-1902.
19. DUDZINSKI DM, IGARASHI J, GREIF D et al. The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 2006; 46:235-276.
20. COCKS TM. Endothelium-dependent vasodilator mechanisms. In: Pharmacology of Vascular Smooth Muscle. Garland CJ, Angus JA, eds. Oxford University Press, Oxford, 1996; pp. 233-251.
21. LUCAS KY, PITARI GM, KAREROUNIAN S et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000; 52:375-413.
22. VENEMA RC. Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin. Int Immunopharmacol 2002; 2:1755-1762.
23. HALL JM. Bradykinin receptors. Gen Pharmacol 1997; 28:1-6.
24. FLEMING I, BUSSE R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol 2003; 284:R1-R12.
25. BAUER PM, YU J, CHEN Y et al. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc Natl Acad Sci U S A 2005; 102:204-209.
26. 4. Eur J Pharmacol 2006; 534:258-263.
27. MINAMI T, AIRD WC. Endothelial cell gene regulation. Trends Cardiovasc Med 2005; 15:174-184.
28. BALCERCZYK A, SOSZYNSKI M, BARTOSZ G. On the specificity of 4-amino-5-methylamino-2′,7′-difluorofluorescein as a probe for nitric oxide. Free Radic Biol Med 2005; 39:327-335.
29. KOJIMA H, URANO Y, KIKUCHI K et al. Fluorescent indicators for imaging nitric oxide production. Angew Chem Int Ed Engl 1999; 38:3209-3212.
30. NAKATSUBO N, KOJIMA H, KIKUCHI K et al. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins. FEBS Lett 1998; 427:263-266.
31. RÄTHEL TR, LEIKERT JF, VOLLMAR AM et al. Application of 4,5-diaminofluorescein to reliably measure nitric oxide released from endothelial cells in vitro. Biol Proc Online 2003; 5:136-142.
32. BRADFORD MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
33. BUSSE R, MÜLSCH A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett 1990; 265:133-136.
34. GIETZEN K. Comparison of the calmodulin antagonists compound 48/80 and calmidazolium. Biochem J 1983; 216:611-616.
35. WANG Q, PATTON WF, HECHTMAN HB et al. Activation of endothelial cell kinin receptors leads to intracellular calcium increases and filamin translocation: regulation by protein kinase C. Cell Signal 1997; 9:595-602.
36. 2+ concentration in endothelial cells by calmodulin antagonists. Biochem Biophys Res Commun 1999; 265:697-702.
37. ALMEIDA-PAULA LD, COSTA-LOTUFO LV, FERREIRA ZS et al. Melatonin modulates rat myotube-acetylcholine receptors by inhibiting calmodulin. Eur J Pharmacol 2005; 525:24-31.
38. WOLFF DJ, LUBESKIE A. Aminoguanidine is an isoformselective, mechanism-based inactivator of nitric oxide synthase. Arch Biochem Biophys 1997; 316:290-301.
39. VISWANATHAN M, LAITINEN JT, SAAVEDRA JM. Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci U S A 1990; 87:6200-6203.
40. 2 melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 2002; 302:1295-1302.
41. EKMEKCIOGLU C, HASLMAYER P, PHILIPP C et al. 24 h variation in the expression of the mt1 melatonin receptor subtype in coronary arteries derived from patients with coronary heart disease. Chronobiol Int 2001; 18:973-985.
42. POZO D, REITER RJ, CALVO JR et al. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 1994; 55:PL455-PL460.
43. BETTAHI I, POZO D, OSUNA C et al. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996; 20:205-210.
44. ACUÑA-CASTROVEJO D, ESCAMES G, LÓPEZ LC et al. Melatonin and nitric oxide. Endocrine 2005; 27:359-368.
45. 2+ entry. J Biol Chem 2000; 275:17979-17985.
46. 2+ homeostasis in endothelial cells. J Pineal Res 2002; 33:37-47.
47. DUBOCOVICH ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995; 16:50-56.
48. KVETNOY IM. Extrapineal melatonin: location and role within diffuse neuroendocrine system. Histochem J 1999; 31:1-12.
49. ESCAMES G, MACIAS M, LEON J et al. Calcium-dependent effects of melatonin inhibition of glutamatergic response in rat striatum. J Neuroendocrinol 2001; 13:459-466.
50. KOPP MD, SCHOMERUS C, DEHGHANI F et al. Pituitary adenylate cyclase-activating polypeptide and melatonin in the suprachiasmatic nucleus: effects on the calcium signal transduction cascade. J Neurosci 1999; 19:206-219.
51. ROMERO MP, GARCIA-PERGAÑEDA A, GUERRERO JM et al. Membrane-bound calmodulin in Xenopus laevis oocytes as a novel binding site for melatonin. FASEB J 1998; 12:1401-1408.
52. OUYANG H, VOGEL HJ. Melatonin and serotonin interactions with calmodulin: NMR, spectroscopic and biochemical studies. Biochim Biophys Acta 1998; 1383:37-47.
53. TURJANSKI AG, ESTRIN DA, ROSENSTEIN RE et al. NMR and molecular dynamics studies of the interaction of melatonin with calmodulin. Protein Sci 2004; 13:2925-2938.
54. BENITEZ-KING G, HUERTO-DELGADILLO L, ANTÓN-TAY F. Melatonin modifies calmodulin cell levels in MDCK and N1E-115 cell lines and inhibits phosphodiesterase activity in vitro. Brain Res 1991; 557:289-292.
55. HUERTO-DELGADILLO L, ANTÓN-TAY F, BENITEZ-KING G. Effects of melatonin on microtubule assembly depend on hormone concentration: role of melatonin as a calmodulin antagonist. J Pineal Res 1994; 17:55-62.
56. 2+/calmodulin-dependent kinase II activity by melatonin. Biochim Biophys Acta 1996; 1290:191-196.
57. SOTO-VEGA E, MEZA I, RAMIREZ-RODRIGUEZ G et al. Melatonin stimulates calmodulin phosphorylation by protein kinase C. J Pineal Res 2004; 37:98-106.
58. WOLFLER A, SCHAUENSTEIN K, LIEBMANN PM. Lack of calmodulin antagonism of melatonin in T-lymphocyte activation. Life Sci 1998; 63:835-842.
59. ALLEGRA M, REITER RJ, TAN D-X et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10.